Unlock instant, AI-driven research and patent intelligence for your innovation.

Resorcinol compound, preparation method thereof and application of resorcinol compound in nervous system diseases

A compound and crystal hydrate technology, applied in the field of medicinal chemistry and chemical synthesis, can solve the problems of low oral bioavailability, poor physical and chemical properties, low melting point, etc.

Pending Publication Date: 2022-05-17
SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI +2
View PDF13 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, CBD has problems such as low oral bioavailability, low melting point, poor physical and chemical properties, poor target action selectivity, etc., and the low human blood concentration when it is taken orally as a monotherapy limits its further clinical application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Resorcinol compound, preparation method thereof and application of resorcinol compound in nervous system diseases
  • Resorcinol compound, preparation method thereof and application of resorcinol compound in nervous system diseases
  • Resorcinol compound, preparation method thereof and application of resorcinol compound in nervous system diseases

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0149] Embodiment 1 prepares following formula compound 1

[0150]

[0151] Refer to the literature (WO 2019033168; WO 2019033164) to prepare methyl cannabidiolate 1-1, take methyl cannabidiolate 1-1 (1.5g) and dissolve it in 10mL methylamine / ethanol solution, and react in a sealed tube at 100 degrees Overnight, TLC monitored the end of the reaction. After concentrating the reaction solution, the product was separated by column chromatography (petroleum ether / ethyl acetate=100 / 1→20 / 1). The product was slurried with petroleum ether and filtered to obtain the title compound 1, 212 mg as a solid. 1 H NMR (400MHz, CDCl 3 )δ11.21(br,1H),6.30(br,1H),6.21(s,1H),5.88(br,1H),5.54(s,1H),4.53(s,1H),4.39(s,1H ),4.07(br,1H),2.98(d,3H),2.64(t,2H),2.41–2.39(m,1H),2.37–2.17(m,1H),2.11–2.05(m,1H), 1.82–1.76(m,2H),1.78(s,3H),1.70(s,3H),1.67–1.56(m,2H),1.37–1.30(m,4H),0.90(t,3H).ESI- MS m / z370.2(M-H) - .

Embodiment 2

[0152] Embodiment 2 prepares following formula compound 2

[0153]

[0154] Add oxalyl chloride (4.1g, 2eq) dropwise to dichloromethane (40mL) and DMF (2.35g, 1.2eq), control the temperature at -10-0°C, keep warm for 2 minutes, dissolve CBD (8.45g) in 40mL di Chloromethane, CBD was added dropwise to the above system at -10°C, and reacted for 0.5 hours. TLC (petroleum ether / ethyl acetate=20 / 1) monitored that the reaction was complete. The reaction was quenched with saturated sodium bicarbonate solution, the dichloromethane layer was separated, dried over anhydrous sodium sulfate, concentrated and passed through the column, PE→PE / acetone=100 / 1, and 9.42g of product 2-a was isolated with a yield of 99% %. The NMR confirmation was consistent with the literature report (WO 2020031179).

[0155] Dissolve compound 2-a in methanol, add 1eq of NaBH 4 , react overnight at room temperature, concentrate to dryness and directly pass through the column to obtain the title compound wit...

Embodiment 3

[0156] Embodiment 3 prepares following formula compound 3

[0157]

[0158] Compound 2-a (3 g) was dissolved in a dichloromethane / methanol (50 / 50 mL) mixed system, methylamine ethanol solution (10 eq) was added, stirred overnight under nitrogen, and the disappearance of the starting material was monitored by TLC. The reaction solution was concentrated to dryness, 50 mL of methanol was added, NaBH was added dropwise under ice-cooling 4 (1eq) in methanol solution, stirred for 15 minutes, the reaction was complete. Add water and ethyl acetate (20mL / 50mL), adjust the pH to 8 with HCl, separate the ethyl acetate layer, concentrate and dry it through the column, PE / EA=2 / 1→EA, and obtain 1.8g of the title compound 3 in a yield of 40 %. 1 HNMR (400MHz, CDCl 3 )δ6.16(s,1H),5.94(m,1H),5.59(s,1H),4.53(m,1H),4.42(m,1H),4.11–4.04(m,1H),3.88(s ,2H),2.51–2.41(m,2H),2.41(s,3H),2.20–2.10(m,1H),2.10–2.05(m,1H),1.81–1.77(m,2H),1.77(s ,3H),1.70(s,3H),1.50–1.43(m,2H),1.32–1.25(m,4H),0.88(t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
wavelengthaaaaaaaaaa
Login to View More

Abstract

The invention relates to a resorcinol compound as well as a preparation method and application thereof in nervous system diseases. Specifically, the invention provides a resorcinol compound represented by a formula (I), an enantiomer, a diastereoisomer, a raceme, a mixture of the enantiomer, the diastereoisomer and the raceme, and pharmaceutically acceptable inorganic or organic salts, crystalline hydrates and solvates of the resorcinol compound. The invention also provides a preparation method of the compound and application of the compound in preparation of medicines for preventing and / or treating central nervous system diseases.

Description

technical field [0001] The present invention relates to the fields of medicinal chemistry and chemical synthesis. Specifically, the present invention relates to a class of resorcinol compounds with novel structures, their preparation methods and their applications in central nervous system diseases. Background technique [0002] In 1940, researchers isolated cannabidiol (CBD) from the plant cannabis, and then identified its chemical structure in 1963, which contained resorcinol and terpene modules. Among the more than 500 natural compounds derived from plant cannabis, CBD has received more and more attention because of its wide range of pharmacological effects and efficacy. [0003] Developed by GW in 2005 (Oromucosal spray with a THC / CBD content ratio of 1) was approved for marketing for the treatment of multiple sclerosis and the relief of cancer-related pain. In June 2018, the FDA approved the marketing of GW's CBD oral liquid, the product name is For the treatment ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C235/60C07C235/62C07C231/02C07C39/23C07C37/00C07C215/50C07C215/52C07C213/02A61P25/00A61P25/08A61P25/18A61P25/22A61P25/24A61P25/28A61P25/14A61P25/16A61P25/20A61P25/30A61P25/04A61K31/137A61K31/05A61K31/166
CPCC07C235/60C07C235/62C07C39/23C07C215/50C07C215/52A61P25/00A61P25/08A61P25/18A61P25/22A61P25/24A61P25/28A61P25/14A61P25/16A61P25/20A61P25/30A61P25/04C07C2601/16C07C2601/02C07B2200/07A61K31/05A61K31/137A61K31/166C07C37/00C07C213/02C07C231/02
Inventor 沈敬山何洋吴春晖公绪栋朱富强
Owner SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI